促肝细胞生长素治疗重型肝炎的疗效评价  

An Evaluation of Prompting Hepatocyte Growth Factor (pHGF) on Advanced Viral Hepatitis

作　　者：闵贤[1] 唐保元[1] 

机构地区：[1]南京医科大学第一附属医院传染病科

出　　处：《南京医科大学学报（自然科学版）》1997年第4期340-342,共3页Journal of Nanjing Medical University(Natural Sciences)

摘　　要：应用从新生公牛肝脏制备的促肝细胞生长素治疗重型肝炎３７例，存活率６４．８６％，与对照组存活率３１．２５％相比有显著性差异（Ｐ＜０．０１）。具体方法为促肝细胞生长素１００～１２０ｍｇ加入１０％葡萄糖液２５０ｍｌ静滴，２个月为一疗程。本品使用安全，无毒副作用，为治疗重型肝炎较为理想的药物。此外，还对促肝细胞生长素的命名、生物学特性以及临床应用作了讨论。The effects of pHGF derived from newborn calves on patients with advanced viral hepatitis were observed. The results showed that total survival rate were 64.86% (24/37) in the pHGF treatment group and 31.25% (10/32) in the control group ( P <0.01). It is suggested that pHGF could greatly elevate the survival rate of the patients with advanced viral hepatitis.

关 键 词：重型肝炎 促肝细胞生长素 病毒性肝炎 药物疗法 

分 类 号：R512.605[医药卫生—内科学] R978.7[医药卫生—临床医学]